Marvell Technology vs. Broadcom: Which Custom AI Chip Stock Has More Upside?

Broadcom reported AI revenue of $8.4B (up 106% YoY) and guides to $10.7B next quarter (potentially +143% YoY), with Counterpoint projecting a ~60% share of the custom AI chip market in 2027 and Broadcom targeting at least $100B in AI revenue in fiscal 2027. Marvell posted fiscal Q4 revenue of $2.22B (+22% YoY) and adj. EPS $0.80 (+33% YoY), raised fiscal 2027 revenue guidance to $11B (from $9.5B) and is targeting $15B for fiscal 2028 after doubling custom processor revenue last year. TrendForce expects ASIC sales to rise ~45% in 2026 (vs GPUs +16%), underpinning tailwinds for both names; valuation differences make Marvell the cheaper value play while Broadcom trades at a premium justified by scale and faster AI revenue growth.

Analysis

Broadcom’s real competitive moat in custom AI appears to be operational rather than purely architectural — control of foundry slots, advanced packaging partners, and supply-chain sequencing lets it convert design wins into revenue faster than peers. That creates a scarcity premium: customers pay for guaranteed ramp and supported SLAs, but it also incentivizes hyperscalers to multi-source or accelerate internal silicon initiatives to reduce single-vendor exposure, a tail that benefits aggressive second-tier vendors who can win “follow” programs.

Marvell’s path to upside is asymmetric: program breadth reduces single-program binary risk and makes it the natural beneficiary if customers prefer diversification or if Broadcom’s allocation tightness bites. Conversely, the margin profile for both suppliers will be sensitive to HBM availability, advanced substrate pricing, and node-yield curves; a temporary supply glut or faster-than-expected TSMC capacity expansion could compress ASPs and re-rate winners down hard within 6–18 months.

Near-term catalysts to watch are (1) quarter-to-quarter reported design-win volumes and shipment cadence from top cloud customers, (2) foundry + OSAT commentary on allocation and yields, and (3) any customer statements about in-sourcing or software stack lock-in. The market is pricing a premium for guaranteed scale — that creates actionable dispersion between a leader that is priced for perfection and a challenger whose optionality may be underappreciated if multi-sourcing accelerates over the next 12–24 months.

Key Decisions for Investors

• Long MRVL LEAPs + defined-risk: Buy MRVL 12–18 month OTM calls (25–35% OTM). Rationale: optionality on multi-program wins and re-rating if customers diversify. Risk: premium paid; Reward: target 50–100% upside if re-rate; stop-loss: 50% of premium.
• Paid-for pair (funded by AVGO calls): Sell AVGO 60–90 day 20–30% OTM call spread and use proceeds to finance the MRVL LEAP. Rationale: monetizes Broadcom’s near-term premium while retaining upside in Marvell. Risk: capped loss on spread if AVGO gaps higher; reward: funds long optionality with limited cash outlay.
• Relative-value pair trade (mid-term): Go long MRVL equity (size X) and short AVGO equity (size Y to be dollar-neutral) with a 6–12 month horizon. Rationale: play valuation compression if multi-sourcing accelerates; Hedge: set trailing stop of 15% on each leg and watch tapeout/ship cadence weekly. Expected outcome: 1.5:1 reward:risk if MRVL captures incremental design wins.
• Event triggers & risk-management: Trim longs on either name if foundry/OSAT commentary signals broad capacity expansion or if hyperscalers announce aggressive in-sourcing; take profits if either stock moves >40% in 30 trading days (indicative of momentum-driven repricing).